pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,022 catalysts · 7,021 phase readout · 2,430 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: filing×type: adcom×type: phase readout×clear all
type
  • phase readout7,021
  • 8k filing2,430
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT05089084: Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)

Sponsor: Arrowhead Pharmaceuticals. Phase: PHASE3. Conditions: Familial Chylomicronemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07775833: Study Protocol: The Efficacy of Mushroom to Reduce Cognitive Decline in At-Risk Middle-aged Adults and Young-olds Living in the Community

Sponsor: National University of Singapore. Phase: NA. Conditions: Dementia, Cognitive Assessment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06334133: Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Sponsor: vTv Therapeutics. Phase: PHASE3. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›TERMINATEDphase readoutNCT02802033: A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders

Sponsor: AO Innovation Translation Center. Phase: . Conditions: Degenerative Diseases, Spinal Cord

full page →ctgov ↗
›COMPLETEDphase readoutNCT07656233: Effect of Isoflavone and Vitamin D Supplementation on Serum Vitamin D Levels, Body Composition, Inflammatory Markers, and Quality of Life in Patients With Inflammatory Bowel Disease

Sponsor: Indonesia University. Phase: NA. Conditions: Ulcerative Colitis (UC), Crohn Disease (CD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06964633: The Ku Ola Project: Enhancing Health Promotion Among Native Hawaiian Men.

Sponsor: University of Hawaii. Phase: NA. Conditions: Health Promotion, Health

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05582447: Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease

Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: . Conditions: Cholestasis, Red Cell Membrane and Enzyme Abnormalities

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06582147: The Social Determinants of Health Screening and Referral Project

Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Preterm Birth

full page →ctgov ↗
›RECRUITINGphase readoutNCT05827549: Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

Sponsor: Ho Joon Im. Phase: PHASE2. Conditions: Acute Lymphoid Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT04419649: A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Sponsor: Takeda. Phase: PHASE2. Conditions: Myelodysplastic Syndromes, Cytopenia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03932136: Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)

Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: PHASE3. Conditions: Clinical High Risk Syndrome of Psychosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07299136: Evaluating the Effect of Hugging and Praying on Traumatic Birth Perception, Birth Pain, and Birth Anxiety

Sponsor: NURTEN ÖZÇALKAP. Phase: NA. Conditions: The Effect of Hugging and Praying on Traumatic Birth Perception, Pain, and Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT05672836: ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Sponsor: Duk-Woo Park, MD. Phase: PHASE4. Conditions: Aortic Valve Stenosis, Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07140211: Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

Sponsor: Marc Blondon. Phase: PHASE3. Conditions: Venous Thromboembolism (VTE), Postpartum

full page →ctgov ↗
›COMPLETEDphase readoutNCT05658471: Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Nicotine Dependence, Tobacco Toxicity, Cardiovascular Risk Factors

full page →ctgov ↗
›TERMINATEDphase readoutNCT05926544: COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: COVID-19

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07443644: Targeting Insomnia to Prevent Depression in the Menopause Transition

Sponsor: SRI International. Phase: NA. Conditions: Insomnia, Menopause Related Conditions

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04617834: Enhancing Rural Health Via Cardiovascular Telehealth for Rural Patients Implementation (E-VICTORS)

Sponsor: Wake Forest University Health Sciences. Phase: . Conditions: Cardiovascular Diseases, Acute Coronary Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07389434: Feasibility, Safety, Cost-effectiveness, and Environmental Impact of Reprocessed Ablation Catheters in PVI

Sponsor: University Hospital Dubrava. Phase: NA. Conditions: Atrial Fibrillation (AF)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04964934: Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: ER-Positive HER2-Negative Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05062434: An Intervention to Impact Cardiovascular Implantable Electronic Device Lead Models Implanted in Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Patient Safety

full page →ctgov ↗
›COMPLETEDphase readoutNCT06096064: Medication Use Evaluation (MUE) for Continuous Heparin Infusions in Hospitalized Patients

Sponsor: Methodist Health System. Phase: . Conditions: Unfractionated Heparin

full page →ctgov ↗
›COMPLETEDphase readoutNCT06344364: Digital Pathology and AI for Liver Outcomes in MASLD

Sponsor: PharmaNest, Inc. Phase: . Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06982209: ANI-Guided Anesthetic Desflurane Consumption

Sponsor: Wonkwang University Hospital. Phase: NA. Conditions: Postoperative Pain, General Anesthesia, Laparoscopic Cholecystectomy

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07373899: Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: . Conditions: Carcinoma, Non-Small-Cell Lung, Neoadjuvant Immunotherapy, Surgery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06692699: The A.R.R.E.S.T.® Spectacle Film Study

Sponsor: nthalmic Pty Ltd. Phase: NA. Conditions: Myopia, Myopia Progression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07394699: Efficiency of Intermittent Hypoxia Intervention in Primary Insomnia

Sponsor: Capital Medical University. Phase: NA. Conditions: Insomnia, Primary

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07693998: Pain Neuroscience Education for Chronic Pain

Sponsor: University of Valencia. Phase: NA. Conditions: Fibromyalgia (FM), Chronic Low Back Pain (CLBP), Chronic Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT06432998: Perineal Massage in Women With Gynecological Cancer

Sponsor: University of Alcala. Phase: NA. Conditions: Cancer Pain, Neck Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07705087: Impact of Plyometric Training Methods on Athletic Performance and Detraining Processes in Youth Female Soccer Players

Sponsor: Pamukkale University. Phase: NA. Conditions: Healthy, Athletic Performance, Detraining

full page →ctgov ↗
›COMPLETEDphase readoutNCT05858593: Positive Youth Development in the Metaverse

Sponsor: University of Georgia. Phase: NA. Conditions: Healthy, Healthy Lifestyle, Childhood ALL, Behavior, Child

full page →ctgov ↗
›COMPLETEDphase readoutNCT03782493: Maximizing Outcomes for Preschoolers With Developmental Language Disorders

Sponsor: Northwestern University. Phase: PHASE2. Conditions: Developmental Language Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07705893: Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg

Sponsor: Ocular Aesthetics, LLC dba Ocular Clinical Trials. Phase: NA. Conditions: Dry Eye

full page →ctgov ↗
›RECRUITINGphase readoutNCT04506593: Indiana University Gastrointestinal Motility Diagnosis Registry

Sponsor: Indiana University. Phase: . Conditions: Eosinophilic Esophagitis, Gastroesophageal Reflux Disease (GERD), Gastroparesis, Functional Vomiting, Irritable Bowel Syndrome (IBS), Constipation, Chronic Intestinal Pseudo-obstruction, Fecal Incontinence, Small Intestinal Bacterial Overgrowth

full page →ctgov ↗
›RECRUITINGphase readoutNCT07324733: Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging

Sponsor: Peking Union Medical College Hospital. Phase: NA. Conditions: Primary Sjögren Syndrome, PET

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03389347: High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Sponsor: University of Washington. Phase: NA. Conditions: Plasma Cell Leukemia, Recurrent Multiple Myeloma, Refractory Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05973838: Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention

Sponsor: University of Maryland, College Park. Phase: NA. Conditions: Polysubstance Addiction, Opioid Medication Assisted Treatment, Treatment Adherence, Retention in Care, Substance-Related Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT07449338: Prospective Cohort Study of Response and Tolerability of Accelerated Intermittent Theta-burst Stimulation (1W-AiTBS)

Sponsor: Vastra Gotaland Region. Phase: . Conditions: Depression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07357948: Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy

Sponsor: Institut Curie. Phase: NA. Conditions: Triple Negative Breast Cancer, Non-Metastatic

full page →ctgov ↗
›COMPLETEDphase readoutNCT05363787: The Effect of Therapeutic Touch on Sleep and Anxiety

Sponsor: KTO Karatay University. Phase: NA. Conditions: Therapeutic Adherence, Nurse-Patient Relations, Sleep Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT05070663: A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)

Sponsor: Sanofi. Phase: . Conditions: Asthma

full page →ctgov ↗
›COMPLETEDphase readoutNCT03499821: Clinical Performance of a Phakic Intraocular Lens (IOL)

Sponsor: Staar Surgical Company. Phase: NA. Conditions: Presbyopia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06358521: Determining the Impact of a Physiotherapist-led Primary Care Model for Hip and Knee Pain - A Cluster Trial

Sponsor: Queen's University. Phase: NA. Conditions: Hip Osteoarthritis, Knee Osteoarthritis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04572321: Youth Depression and Suicide Research Network

Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Depression, Suicide, Suicidal Ideation, Suicide, Attempted, Depressive Disorder, Depressive Symptoms, Depressive Episode, Depression and Suicide, Depression, Teen, Depression, Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT07207993: Evaluating Health Outcomes of AI-Based Fitness Wearables and App Programs in Older Adults Living Alone With Cognitive Decline

Sponsor: The University of Tennessee, Knoxville. Phase: NA. Conditions: Older Adults With Cognitive Decline, Older Adults, AI-Based Fitness, Wearables, Cognitive Decline, Physical Activity, Physical Inactivity

full page →ctgov ↗
›COMPLETEDphase readoutNCT06447493: Effects of Spencer's Technique on Shoulder Function

Sponsor: Edward Via Virginia College of Osteopathic Medicine. Phase: NA. Conditions: Shoulder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07349563: Effects of Nature-Based Virtual Reality and 2D Nature Videos on OSCE Exam Stress in Nursing Students

Sponsor: Acibadem University. Phase: NA. Conditions: Stress, Virtual Reality, Students, Nursing

full page →ctgov ↗
›RECRUITINGphase readoutNCT05438563: MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

Sponsor: Mayo Clinic. Phase: NA. Conditions: Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06309121: Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents

Sponsor: Fundació Sant Joan de Déu. Phase: NA. Conditions: Obesity, Childhood, Obesity, Adolescent

full page →ctgov ↗
›COMPLETEDphase readoutNCT04256421: A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Small Cell Lung Cancer

full page →ctgov ↗
← prev
page 137 of 141
next →